| Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer JM Jiménez-Vacas, V Herrero-Aguayo, AJ Montero-Hidalgo, ... EBioMedicine 51, 2020 | 96 | 2020 |
| Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3 AC Fuentes-Fayos, MC Vázquez-Borrego, JM Jimenez-Vacas, L Bejarano, ... Brain 143 (11), 3273-3293, 2020 | 79 | 2020 |
| Type 2 diabetes in neuroendocrine tumors: are biguanides and statins part of the solution? AD Herrera-Martínez, S Pedraza-Arevalo, F L-López, MD Gahete, ... The Journal of Clinical Endocrinology & Metabolism 104 (1), 57-73, 2019 | 50 | 2019 |
| Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors S Pedraza-Arévalo, MD Gahete, E Alors-Pérez, RM Luque, JP Castaño Reviews in Endocrine and Metabolic Disorders 19, 179-192, 2018 | 50 | 2018 |
| Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors AD Herrera-Martínez, MD Gahete, S Pedraza-Arevalo, ... Endocrine 59, 426-437, 2018 | 41 | 2018 |
| Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer S Pedraza‐Arévalo, D Hormaechea‐Agulla, E Gómez‐Gómez, ... The Prostate 77 (15), 1499-1511, 2017 | 40 | 2017 |
| Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug E Alors-Perez, R Blázquez-Encinas, S Alcalá, C Viyuela-García, ... Journal of Experimental & Clinical Cancer Research 40, 1-21, 2021 | 38 | 2021 |
| Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive … D Hormaechea-Agulla, E Gómez-Gómez, A Ibáñez-Costa, ... Cancer letters 383 (1), 125-134, 2016 | 36 | 2016 |
| Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy A Ibáñez-Costa, C Perez-Sanchez, AM Patiño-Trives, M Luque-Tevar, ... Annals of the Rheumatic Diseases 81 (1), 56-67, 2022 | 30 | 2022 |
| An HNF1α truncation associated with maturity-onset diabetes of the young impairs pancreatic progenitor differentiation by antagonizing HNF1β function AM Cujba, ME Alvarez-Fallas, S Pedraza-Arevalo, A Laddach, ... Cell Reports 38 (9), 2022 | 23 | 2022 |
| Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors S Pedraza-Arevalo, E Alors-Pérez, R Blázquez-Encinas, ... Translational Research 251, 63-73, 2023 | 16 | 2023 |
| Oncogenic role of secreted engrailed homeobox 2 (EN2) in prostate cancer E Gomez-Gomez, JM Jimenez-Vacas, S Pedraza-Arevalo, F Lopez-Lopez, ... Journal of Clinical Medicine 8 (9), 1400, 2019 | 16 | 2019 |
| Mouse models of endocrine tumors MD Gahete, JM Jiménez-Vacas, E Alors-Pérez, V Herrero-Aguayo, ... Journal of Endocrinology 240 (3), R73-R96, 2019 | 14 | 2019 |
| Not so giants: mice lacking both somatostatin and cortistatin have high GH levels but show no changes in growth rate or IGF-1 levels S Pedraza-Arévalo, J Córdoba-Chacón, AI Pozo-Salas, F L.-López, ... Endocrinology 156 (6), 1958-1964, 2015 | 12 | 2015 |
| Ghrelin-O-acyltransferase (GOAT) enzyme as a novel potential biomarker in gastroenteropancreatic neuroendocrine tumors AD Herrera-Martínez, MD Gahete, R Sánchez-Sánchez, E Alors-Perez, ... Clinical and Translational Gastroenterology 9 (10), e196, 2018 | 11 | 2018 |
| Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential E Alors-Pérez, S Pedraza-Arevalo, R Blázquez-Encinas, ... Journal of Experimental & Clinical Cancer Research 42 (1), 282, 2023 | 9 | 2023 |
| Epigenetic and post‐transcriptional regulation of somatostatin receptor subtype 5 (SST5) in pituitary and pancreatic neuroendocrine tumors S Pedraza‐Arevalo, A Ibáñez‐Costa, R Blázquez‐Encinas, MR Branco, ... Molecular Oncology 16 (3), 764-779, 2022 | 9 | 2022 |
| Stem/progenitor cells in normal physiology and disease of the pancreas MEA Fallas, S Pedraza-Arevalo, AM Cujba, T Manea, C Lambert, ... Molecular and Cellular Endocrinology 538, 111459, 2021 | 9 | 2021 |
| Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBioMedicine 51 102547 JM Jiménez-Vacas, V Herrero-Aguayo, AJ Montero-Hidalgo, ... | 8 | 2020 |
| The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities R Blázquez-Encinas, MT Moreno-Montilla, V García-Vioque, ... Reviews in Endocrine and Metabolic Disorders 24 (2), 267-282, 2023 | 7 | 2023 |
